256 studies found for:    "nonsyndromic deafness" OR "Hearing Loss" OR "Deafness"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Genetic Testing in Detection of Late-Onset Hearing Loss
Conditions: Hearing Loss;   Late-Onset Hearing Loss;   Deafness
Intervention: Genetic: No intervention
2 Recruiting Outcomes In Children With Developmental Delay And Deafness
Conditions: Deafness;   Hearing Loss
Interventions: Device: cochlear implantation;   Device: hearing aids
3 Completed Bone Conduction Auditory Performance Via the Tooth for Single-Sided Deafness
Conditions: Unilateral Hearing Loss;   Single Sided Deafness
Intervention: Device: The Sonitus Bone Conduction Hearing System
4 Completed Hearing Loss Prevention for Veterans
Condition: Hearing Loss, Noise-Induced
Interventions: Behavioral: Multimedia hearing loss prevention program;   Behavioral: Hearing Conservation brochure
5 Recruiting Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss
Conditions: Hearing Loss;   Deafness;   Hearing Loss, Sensorineural;   Hearing Disorders;   Ear Diseases
Interventions: Drug: Ancrod;   Drug: Saline solution
6 Completed
Has Results
Antioxidation Medication for Noise-induced Hearing Loss
Condition: Hearing Loss
Interventions: Drug: N-acetylcysteine (NAC);   Drug: glucose
7 Not yet recruiting Prevention of Noise-induced Hearing Loss
Condition: Noise-induced Hearing Loss
Interventions: Drug: Zonisamide;   Drug: Methylprednisolone
8 Recruiting Phase 3 Clinical Trial: D-Methionine to Reduce Noise-Induced Hearing Loss (NIHL)
Condition: Noise-Induced Hearing Loss
Interventions: Drug: D-methionine, oral liquid suspension;   Other: Placebo Comparator
9 Completed Micronutrients to Prevent Noise-induced Hearing Loss
Condition: Noise-Induced Hearing Loss
Interventions: Dietary Supplement: Micronutrient Supplement, capsule form;   Other: Placebo, capsule form;   Drug: Dietary supplement consisting of beta-carotene, vitamins C and E, magnesium;   Other: Placebo Control
10 Completed Genetic Study of Age Related Hearing Loss
Conditions: Age-related Hearing Loss;   Presbycusis
Intervention: Genetic: genes
11 Active, not recruiting Evaluation of the Effectiveness of Bone-anchored Hearing Aids (Baha)
Conditions: Conductive Hearing Loss;   Mixed Hearing Loss;   Unilateral Deafness
Intervention: Other: audiological test battery
12 Completed Comparison of BAHA and CROS Hearing Aid in Single-Sided Deafness
Conditions: Unilateral Hearing Loss;   Unilateral Deafness
Intervention: Device: CROS hearing aid
13 Completed
Has Results
Sudden Deafness Treatment Trial
Condition: Sudden Deafness
Interventions: Drug: prednisone;   Drug: methylprednisolone sodium succinate
14 Recruiting Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness
Conditions: Hearing Loss;   Partial Deafness;   Hearing Disorders;   Ear Diseases;   Otorhinolaryngologic Diseases
Interventions: Device: HiRes 90K™ Advantage implant with HiFocus™ Mid-Scala electrode;   Device: EAS sound processor
15 Completed Genetic Studies of Tone Deafness
Conditions: Healthy;   Tone Deafness
Intervention:
16 Completed Efficacy of the Bone-Anchored Hearing Aid for Unilateral Deafness
Condition: Unilateral Deafness
Intervention: Device: Bone-anchored hearing aid
17 Completed Hearing Loss and Complaint in Patients With Head and Neck Cancer Treated With Radiotherapy
Condition: Hearing Loss
Intervention:
18 Completed Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss
Condition: Hearing Loss
Interventions: Drug: AM-111;   Drug: placebo
19 Recruiting Maximizing Language Development in Children With Hearing Loss
Condition: Hearing Loss
Intervention: Behavioral: Early language intervention
20 Not yet recruiting SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Conditions: Lung Cancer;   Head and Neck Cancer;   Hearing Loss;   Ototoxicity;   Tinnitus;   Neuropathy
Interventions: Drug: SPI-1005 Low Dose;   Drug: SPI-1005 Middle Dose;   Drug: SPI-1005 High Dose;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years